4 years ago

Lifebit.ai Secures $60 Million to Advance Global Biomedical Data Access

  • London-based genomic data startup Lifebit.ai has raised $60 million in a Series B funding round led by Tiger Global Management

  • The company provides access to global biomedical data, enabling researchers and organisations to accelerate drug discovery and precision medicine

  • The funding will be used for global expansion, customer success, and team growth.

      • ProblemHealthcare

      "Researchers and scientists often lack access to the vast amounts of biomedical data needed to cure diseases, hindering progress in precision medicine and drug discovery."

      Solution

      "Lifebit provides a secure and scalable enterprise data platform that allows organizations to access, analyze, and collaborate on sensitive biomedical data while ensuring privacy and compliance."

      Covered on